Skip to main content

and
  1. Article

    Open Access

    Prognostic model of long-term advanced stage (IIIB-IV) EGFR mutated non-small cell lung cancer (NSCLC) survivors using real-life data

    There is a lack of useful diagnostic tools to identify EGFR mutated NSCLC patients with long-term survival. This study develops a prognostic model using real world data to assist clinicians to predict survival...

    Lourdes Gutiérrez, Ana Royuela, Enric Carcereny, Rafael López-Castro in BMC Cancer (2021)

  2. Article

    Open Access

    Effects of anti-PD-1 immunotherapy on tumor regression: insights from a patient-derived xenograft model

    Immunotherapies, such as checkpoint blockade of programmed cell death protein-1 (PD-1), have resulted in unprecedented improvements in survival for patients with lung cancer. Nonetheless, not all patients bene...

    Asunción Martín-Ruiz, Carmen Fiuza-Luces, Esther Martínez-Martínez in Scientific Reports (2020)

  3. Article

    Open Access

    PGC-1alpha levels correlate with survival in patients with stage III NSCLC and may define a new biomarker to metabolism-targeted therapy

    Lung cancer remains the leading cause of cancer-related death worldwide, with one-third diagnosed with locally advanced (stage III) disease. Preoperative induction chemo-radiotherapy is key for the treatment o...

    Alberto Cruz-Bermúdez, Ramiro J. Vicente-Blanco in Scientific Reports (2017)

  4. No Access

    Article

    Functional Analysis of HIV-1 Reverse Transcriptase Motif C: Site-Directed Mutagenesis and Metal Cation Interaction

    Motif C, present in all polymerases, has been proposed to be part of the catalytic and metal binding site of the enzyme, suggesting that polymerases have a common origin. Previously, we have shown that the me...

    Verónica Valverde-Garduño, Patricio Gariglio in Journal of Molecular Evolution (1998)